These results suggest there is no excess cardiovascular risk with tirzepatide and are consistent with the improvements of numerous surrogate markers of cardiovascular health, including weight reduction, glycemic control with less hypoglycemia, blood pressure reduction, and improvements in the lipid profile
This helps to open up the airways and make breathing easier
two oral GLP-1 RA candidates expected to begin clinical trials imminently
Motivul rezultatelor mai bune au fost datorate de arderea grsimilor i de meninerea glicogenul muscular
Your healthcare provider may recommend strategies to manage symptoms or temporarily adjust your treatment
Practical steps for day one: Keep a symptom diary from the outset Stay well hydrated throughout the day Avoid large, heavy, or high-fat meals immediately after your injection Have your healthcare team's and trial team's contact details readily available If you experience urgent or worsening symptoms, call NHS 111 for advice